Characteristics, patterns of co-medications and dose titration in heart failure patients using vericiguat in real-world clinical settings in Japan.
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
Bayer Yakuhin, Ltd., Osaka (Japan)
6 More presentations in this session
Post-procedural mitral regurgitation as an independent predictor of morbidity and mortality outcomes
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Doctor M. Leite (Porto, PT)
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Professor D. Galzerano (Riyadh, SA)
Doctor M. Oerlemans (Utrecht, NL)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
